Trans Ova Laboratories India Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 12-12-2024
- Paid Up Capital ₹ 7.23 M
as on 12-12-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 1074592.88%
(FY 2023)
- Net Worth 6.97%
(FY 2023)
- Total Assets 8.82%
(FY 2023)
About Trans Ova Laboratories India
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.23 M, as per Ministry of Corporate Affairs (MCA) records.
Deepti Goyal, David Faber, and Katherine Jess serve as directors at the Company.
- CIN/LLPIN
U01100DL2020FTC368066
- Company No.
368066
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
14 Aug 2020
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Trans Ova Laboratories India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
David Faber  | Director | 14-Aug-2020 | Current |
Deepti Goyal  | Director | 14-Aug-2020 | Current |
| Katherine Jess | Director | 14-Aug-2020 | Current |
Financial Performance of Trans Ova Laboratories India.
Trans Ova Laboratories India Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 1074592.88% increase in profit. The company's net worth moved up by a moderate rise of 6.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Trans Ova Laboratories India?
In 2023, Trans Ova Laboratories India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Broccoli And Carrots Global Services Private LimitedActive 10 years 13 daysDeepti Goyal is a mutual person
- Lumine Software Solutions India Private LimitedActive 1 year 1 month
Deepti Goyal is a mutual person
- Lumine Software Solutions India (Digital & Messaging) Private LimitedActive 1 year 8 days
Deepti Goyal is a mutual person
- Lumine Software Solutions (Motive) India Private LimitedActive 1 year 2 days
Deepti Goyal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Trans Ova Laboratories India?
Trans Ova Laboratories India has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trans Ova Laboratories India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trans Ova Laboratories India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
